Showing results (81-90 of 3,348) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|February 1, 2003
Cost-minimisation study of dorzolamide versus brinzolamide in the treatment of ocular hypertension and primary open-angle glaucoma: in four European countriesJean-Francois Rouland, Claude Le Pen, Carlos Gouveia Pinto, et al.
Pharmacoeconomics|June 8, 2002
Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literatureGary Ginsberg, Serena Lowe
Pharmacoeconomics|June 8, 2002
Estimating the effect of changes in body mass index on health state preferencesZafar Hakim, Anne Wolf, Louis P Garrison
Pharmacoeconomics|August 7, 2002
The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical studyDavid Price, John Haughney, Martin Duerden, et al.
Pharmacoeconomics|August 7, 2002
Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantationMelissa Young, Greg L Plosker
Pharmacoeconomics|September 19, 2002
Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature reviewMary Kay Margolis, Karin Coyne, Tessa Kennedy-Martin, et al.
Pharmacoeconomics|September 19, 2002
Long term cost-of-illness in stroke: an international reviewKrista A Payne, Krista F Huybrechts, J Jaime Caro, et al.
Pharmacoeconomics|July 16, 2003
A role for two-stage pharmacoeconomic appraisal? Is there a role for interim approval of a drug for reimbursement based on modelling studies with subsequent full approval using phase III data?Suzanne Hill, Nick Freemantle
Pharmacoeconomics|July 16, 2003
Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitusJoe W Ramsdell, Seth N Braunstein, Jennifer M Stephens, et al.
Pharmacoeconomics|June 28, 2003
Cost effectiveness of adding folinic acid to fluorouracil plus levamisole as adjuvant chemotherapy in patients with colon cancer in GermanyBrigitta U M Monz, Hans-Helmut König, Reiner Leidl, et al.
Pageof 335